{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:55:54Z","timestamp":1771275354056,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41440-020-0449-6","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T08:05:50Z","timestamp":1588838750000},"page":"591-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies"],"prefix":"10.1038","volume":"43","author":[{"given":"Goran","family":"Koracevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sladjana","family":"Micic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milovan","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miloje","family":"Tomasevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomislav","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radmila","family":"Velickovic Radovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Lovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miomir","family":"Randjelovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Koracevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaklina","family":"Ristic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","unstructured":"Argulian E, Bangalore S, Messerli FH. Misconceptions and facts about beta-blockers. Am J Med. (Epub ahead of print feb 2019. pii: S0002-9343(19)30152-4. https:\/\/doi.org\/10.1016\/j.amjmed.2019.01.039.","DOI":"10.1016\/j.amjmed.2019.01.039"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"e4908","DOI":"10.1097\/MD.0000000000004908","volume":"95","author":"M Qvarnstr\u00f6m","year":"2016","unstructured":"Qvarnstr\u00f6m M, Kahan T, Kieler H, Brandt L, Hasselstr\u00f6m J, Bostr\u00f6m KB, et al. Persistence to antihypertensive drug classes: a cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD). Med (Baltim). 2016;95:e4908. https:\/\/doi.org\/10.1097\/MD.0000000000004908.","journal-title":"Med (Baltim)"},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3346\/jkms.2015.30.12.1800","volume":"30","author":"YM Ah","year":"2015","unstructured":"Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, et al. Persistence with antihypertensive medications in uncomplicated treatment-na\u00efve patients: effects of initial therapeutic classes. J Korean Med Sci. 2015;30:1800\u20136. https:\/\/doi.org\/10.3346\/jkms.2015.30.12.1800.","journal-title":"J Korean Med Sci"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/ajh\/hpu199","volume":"28","author":"N Moise","year":"2015","unstructured":"Moise N, Schwartz J, Bring R, Shimbo D, Kronish IM. Antihypertensive drug class and adherence: an electronic monitoring study. Am J Hypertens. 2015;28:717\u201321. https:\/\/doi.org\/10.1093\/ajh\/hpu199.","journal-title":"Am J Hypertens"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, AgabitiRosei E, Azizi M, Burnier M, et al. Authors\/Task Force Members:2018 ESC\/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s0140-6736(73)90235-3","volume":"7795","author":"R Slome","year":"1973","unstructured":"Slome R. Withdrawal of propranolol and myocardial infarction. Lancet. 1973;7795:156. https:\/\/doi.org\/10.1016\/s0140-6736(73)90235-3.","journal-title":"Lancet"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJM197508282930902","volume":"293","author":"RR Miller","year":"1975","unstructured":"Miller RR, Olson HG, Amsterdam EA, Mason DT. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N. Engl J Med. 1975;293:416\u20138. https:\/\/doi.org\/10.1056\/NEJM197508282930902.","journal-title":"N. Engl J Med"},{"key":"449_CR8","unstructured":"Koracevic G. Significance of \u201cBeta Blocker Rebound Phenomenon\u201d and New Suggestions how to Avoid it. In: Rivas-Echeverria C, Allegaert K, Wainstein DE editors. Proceedings of the World Medical Conference: Prague, Czech Republic. Athens, Greece: World Scientific and Engineering Academy and Society; 2011. pp. 79\u201384."},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/jhh.2017.1","volume":"31","author":"FF Alharbi","year":"2017","unstructured":"Alharbi FF, Souverein PC, de Groot MC, Maitland-van der Zee AH, de Boer A, Klungel OH. Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study. J Hum Hypertens. 2017;31:537\u201344. https:\/\/doi.org\/10.1038\/jhh.2017.1.","journal-title":"J Hum Hypertens"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"e004356","DOI":"10.1161\/CIRCOUTCOMES.117.004356","volume":"11","author":"A Neumann","year":"2018","unstructured":"Neumann A, Maura G, Weill A, Alla F, Danchin N. Clinical events after discontinuation of \u03b2-Blockers in patients without heart failure optimally treated after acute myocardial infarction a cohort study on the French Healthcare Databases. Circ Cardiovasc Qual Outcomes. 2018;11:e004356. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.117.004356.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5633\/amm.2018.0420","volume":"57","author":"M Kora\u0107evi\u0107","year":"2018","unstructured":"Kora\u0107evi\u0107 M, Lali\u0107 J, Nedeljkovi\u0107 S, Kora\u0107evi\u0107 G. Rebound phenomenon \u2013 important and ubiquitous in pharmacotherapy. Acta Med Medianae. 2018;57:148\u201352. https:\/\/doi.org\/10.5633\/amm.2018.0420","journal-title":"Acta Med Medianae"},{"key":"449_CR12","unstructured":"Opie LH. B-blocking agents. In: Opie LH, Gersh B editors. Drugs for the Heart. W.B. Saunders, Philadelphia, USA. 2019. http:\/books.google.com. Accessed 21 Dec 2019."},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/JQSH.JQSH_21_18","volume":"2","author":"M Elshami","year":"2019","unstructured":"Elshami M, Dabbour R, Alkhatib M, Abdalghafoor T, Alaloul E, Habib M, et al. Evaluating the adherence to guidelines for management of acute heart failure in the Gaza Strip hospitals: a medical chart-based review study. JQSH. 2019;2:21\u201329. https:\/\/doi.org\/10.4103\/JQSH.JQSH_21_18.","journal-title":"JQSH"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159\u2013219. https:\/\/doi.org\/10.1093\/eurheartj\/eht151.","journal-title":"Eur Heart J"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA \/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127\u2013248. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006.","journal-title":"J Am Coll Cardiol"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","volume":"25","author":"J L\u00f3pez-Send\u00f3n","year":"2004","unstructured":"L\u00f3pez-Send\u00f3n J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004;25:1341\u201362. https:\/\/doi.org\/10.1016\/j.ehj.2004.06.002.","journal-title":"Eur Heart J"},{"key":"449_CR17","doi-asserted-by":"publisher","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure \u2013 Web Addenda. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. 2016 Addenda Web Tables \u2013 EHJ. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240\u2013327. https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8776.","journal-title":"Circulation"},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","volume":"126","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas P, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354\u2013471. https:\/\/doi.org\/10.1161\/CIR.0b013e318277d6a0.","journal-title":"Circulation"},{"key":"449_CR20","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al; 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. https:\/\/academic.oup.com\/eurheartj\/advance-article-abstract\/doi\/10.1093\/eurheartj\/ehz425\/5556137. Epub ahead of print."},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","volume":"64","author":"LA Fleisher","year":"2014","unstructured":"Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64:e77\u2013137. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.944.","journal-title":"J Am Coll Cardiol"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/med.21476","volume":"38","author":"P Mlad\u011bnka","year":"2018","unstructured":"Mlad\u011bnka P, Applov\u00e1 L, Pato\u010dka J, Costa VM, Remiao F, Pourova J, et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018;38:1332\u2013403. https:\/\/doi.org\/10.1002\/med.21476.","journal-title":"Med Res Rev"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40885-018-0104-6","volume":"25","author":"EA Gebreyohannes","year":"2019","unstructured":"Gebreyohannes EA, Bhagavathula AS, Abebe TB, Tefera YG, Abegaz TM. Adverse effects and non-adherence to antihypertensive medications in University Nof Gondar Comprehensive Specialized Hospital. Clin Hypert. 2019;25:1\u20139. https:\/\/doi.org\/10.1186\/s40885-018-0104-6.","journal-title":"Clin Hypert"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/1755-5922.12197","volume":"34","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Ah YM, Kong J, Choi KH, Kim B, Han N, et al. Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based study. Cardiovasc Ther. 2016;34:268\u201375. https:\/\/doi.org\/10.1111\/1755-5922.12197.","journal-title":"Cardiovasc Ther"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","volume":"41","author":"CA Huber","year":"2019","unstructured":"Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T. Post-myocardial Infarction (MI) care: medication adherence for secondary prevention after MI in a large real-world population. Clin Ther. 2019;41:107\u201317. https:\/\/doi.org\/10.1016\/j.clinthera.2018.11.012.","journal-title":"Clin Ther"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bja.2018.02.004","volume":"121","author":"ME J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen ME, Andersson C, Venkatesan S, Sanders RD. Beta-blockers in noncardiac surgery: did observational studies put us back on safe ground? Br J Anaesth. 2018;121:16\u201325. https:\/\/doi.org\/10.1016\/j.bja.2018.02.004.","journal-title":"Br J Anaesth"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/S0140-6736(05)67575-7","volume":"366","author":"DG Beevers","year":"2005","unstructured":"Beevers DG. The end of beta blockers for uncomplicated hypertension? Lancet. 2005;366:1510\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(05)67575-7.","journal-title":"Lancet"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","volume":"66","author":"X Rossello","year":"2015","unstructured":"Rossello X, Pocock SJ, Julian DG. Long-term use of cardiovascular drugs: challenges for research and for patient care. J Am Coll Cardiol. 2015;66:1273\u201385. https:\/\/doi.org\/10.1016\/j.jacc.2015.07.018.","journal-title":"J Am Coll Cardiol"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578.","volume":"69","author":"TB Dondo","year":"2017","unstructured":"Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, et al. \u03b2-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol. 2017;69:2710\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2017.03.578.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"449_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jdv.13542","volume":"30","author":"E Daud\u00e9n","year":"2016","unstructured":"Daud\u00e9n E, Puig L, Ferr\u00e1ndiz C, S\u00e1nchez-Carazo JL, Hernanz-Hermosa JM. Consensus document on the evaluation and treatment of moderate-to-severe pso-riasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology. J Eur Acad Dermatol. 2016;30(Suppl 2):1\u201318. https:\/\/doi.org\/10.1111\/jdv.13542.","journal-title":"J Eur Acad Dermatol"},{"issue":"Suppl 1","key":"449_CR31","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1097\/00005344-200312001-00019","volume":"42","author":"K Kario","year":"2003","unstructured":"Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharm. 2003;42(Suppl 1):S87\u201391. https:\/\/doi.org\/10.1097\/00005344-200312001-00019.","journal-title":"J Cardiovasc Pharm"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949\u20133003. https:\/\/doi.org\/10.1093\/eurheartj\/eht296.","journal-title":"Eur Heart J"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3399\/bjgp12X630232","volume":"62","author":"T McCormack","year":"2012","unstructured":"McCormack T, Krause T, O\u2019Flynn N. Management of hypertension in adults in primary care: NICE guideline. Br J Gen Pr. 2012;62:163\u20134. https:\/\/doi.org\/10.3399\/bjgp12X630232.","journal-title":"Br J Gen Pr"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cjca.2018.02.022","volume":"34","author":"KA Nerenberg","year":"2018","unstructured":"Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, et al. Hypertension Canada\u2019s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018;34:506\u201325. https:\/\/doi.org\/10.1016\/j.cjca.2018.02.022.","journal-title":"Can J Cardiol"},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0449-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:27Z","timestamp":1684617867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-0449-6","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"22 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}